{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2018-03-05T23%3A54%3A05.960Z&dateTabled=2018-03-05&max-questionFirstAnswered.=2018-03-08T12%3A40%3A26.17Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?max-ddpCreated=2018-03-05T23%3A54%3A05.960Z&dateTabled=2018-03-05&max-questionFirstAnswered.=2018-03-08T12%3A40%3A26.17Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2018-03-05T23%3A54%3A05.960Z&dateTabled=2018-03-05&_metadata=all&max-questionFirstAnswered.=2018-03-08T12%3A40%3A26.17Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&max-ddpCreated=2018-03-05T23%3A54%3A05.960Z&dateTabled=2018-03-05&max-questionFirstAnswered.=2018-03-08T12%3A40%3A26.17Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2018-03-05T23%3A54%3A05.960Z&dateTabled=2018-03-05&max-questionFirstAnswered.=2018-03-08T12%3A40%3A26.17Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2018-03-05T23%3A54%3A05.960Z&dateTabled=2018-03-05&max-questionFirstAnswered.=2018-03-08T12%3A40%3A26.17Z", "items" : [{"_about" : "http://data.parliament.uk/resources/854855", "AnsweringBody" : [{"_value" : "Ministry of Defence"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/854855/answer", "answerText" : {"_value" : "
We regularly monitor the status of our most important suppliers and have robust, sustainable measures in place to reduce risk should there be a collapse.<\/p>
We assess the legal and financial status of the company before placing a contract. We then monitor the financial health and performance of the company throughout the contract, taking action as appropriate.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3910", "label" : {"_value" : "Biography information for Guto Bebb"} } , "answeringMemberConstituency" : {"_value" : "Aberconwy"} , "answeringMemberPrinted" : {"_value" : "Guto Bebb"} , "dateOfAnswer" : {"_value" : "2018-03-05", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-03-05T17:03:45.52Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "11"} , "answeringDeptShortName" : {"_value" : "Defence"} , "answeringDeptSortName" : {"_value" : "Defence"} , "date" : {"_value" : "2018-03-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Ministry of Defence: Contracts"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "What contingency plans his Department has put in place in the event that a private contractor to the Department collapses.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4634", "label" : {"_value" : "Biography information for Christine Jardine"} } , "tablingMemberConstituency" : {"_value" : "Edinburgh West"} , "tablingMemberPrinted" : [{"_value" : "Christine Jardine"} ], "uin" : "904170"} , {"_about" : "http://data.parliament.uk/resources/854856", "AnsweringBody" : [{"_value" : "Ministry of Defence"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/854856/answer", "answerText" : {"_value" : "
As the Prime Minister said in her 17 February speech in Munich, Europe\u2019s security is our security.<\/p>
<\/p>
We want to co-operate closely with the full range of European partners, including the EU, to keep our citizens safe from threats and to defend our shared values.<\/p>
<\/p>
This could include continued UK participation in specific EU-led operations and missions. We are also cooperating with EU partners to develop Europe\u2019s military capabilities in a way that strengthens NATO and our wider alliances too.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4108", "label" : {"_value" : "Biography information for Sir Gavin Williamson"} } , "answeringMemberConstituency" : {"_value" : "South Staffordshire"} , "answeringMemberPrinted" : {"_value" : "Gavin Williamson"} , "dateOfAnswer" : {"_value" : "2018-03-05", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-03-05T17:02:48.303Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "11"} , "answeringDeptShortName" : {"_value" : "Defence"} , "answeringDeptSortName" : {"_value" : "Defence"} , "date" : {"_value" : "2018-03-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "EU Defence Policy"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "What steps his Department is taking to maintain defence co-operation with the EU after the UK leaves the EU.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/151", "label" : {"_value" : "Biography information for Tom Brake"} } , "tablingMemberConstituency" : {"_value" : "Carshalton and Wallington"} , "tablingMemberPrinted" : [{"_value" : "Tom Brake"} ], "uin" : "904171"} , {"_about" : "http://data.parliament.uk/resources/854857", "AnsweringBody" : [{"_value" : "Ministry of Defence"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/854857/answer", "answerText" : {"_value" : "
The Modernising Defence Programme is being undertaken to ensure that our Armed Forces have the right processes and capabilities in place to address the evolving threats that we face.<\/p>
<\/p>
As the hon. Member will be aware, I have had regular discussions with the Chancellor since arriving at the Ministry of Defence and will continue to do so as the Modernising Defence Programme progresses.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4108", "label" : {"_value" : "Biography information for Sir Gavin Williamson"} } , "answeringMemberConstituency" : {"_value" : "South Staffordshire"} , "answeringMemberPrinted" : {"_value" : "Gavin Williamson"} , "dateOfAnswer" : {"_value" : "2018-03-05", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-03-05T17:02:05.603Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "11"} , "answeringDeptShortName" : {"_value" : "Defence"} , "answeringDeptSortName" : {"_value" : "Defence"} , "date" : {"_value" : "2018-03-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Armed Forces: Finance"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "What recent assessment he has made of the adequacy of funding for the armed forces; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3952", "label" : {"_value" : "Biography information for Mr Toby Perkins"} } , "tablingMemberConstituency" : {"_value" : "Chesterfield"} , "tablingMemberPrinted" : [{"_value" : "Toby Perkins"} ], "uin" : "904174"} , {"_about" : "http://data.parliament.uk/resources/855487", "AnsweringBody" : [{"_value" : "Department for Digital, Culture, Media and Sport"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/855487/answer", "answerText" : {"_value" : "
DCMS does not centrally collect the specific data requested.<\/p>
<\/p>
Information regarding contracts above the value of £10,000 is published on Contracts Finder on GOV.UK, available at https://www.gov.uk/contracts-finder.<\/p>
<\/p>
The Interception of Communications Commissioner and the Information Commissioner\u2019s Office also have responsibilities in this area.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4115", "label" : {"_value" : "Biography information for Margot James"} } , "answeringMemberConstituency" : {"_value" : "Stourbridge"} , "answeringMemberPrinted" : {"_value" : "Margot James"} , "dateOfAnswer" : {"_value" : "2018-03-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-03-08T11:43:44.617Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "10"} , "answeringDeptShortName" : {"_value" : "Digital, Culture, Media and Sport"} , "answeringDeptSortName" : {"_value" : "Digital, Culture, Media and Sport"} , "date" : {"_value" : "2018-03-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Department for Digital, Culture, Media and Sport: Internet"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Digital, Culture, Media and Sport, what estimate he has made of the volume of UK citizens\u2019 data held by companies (a) supplying cloud services to his department and (b) contracted to deliver cloud services on behalf of his Department that is subject to information requests from US Government bodies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/261", "label" : {"_value" : "Biography information for James Gray"} } , "tablingMemberConstituency" : {"_value" : "North Wiltshire"} , "tablingMemberPrinted" : [{"_value" : "James Gray"} ], "uin" : "130794"} , {"_about" : "http://data.parliament.uk/resources/855493", "AnsweringBody" : [{"_value" : "Department for Work and Pensions"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/855493/answer", "answerText" : {"_value" : "
The information requested is shown in the table below.<\/p>
<\/p>
Number of Employment and Support Allowance (ESA) claimants with at least one work capability assessment outcome, with a main disabling condition of Cystic Fibrosis, Motor Neurone Disease, Multiple Sclerosis, Parkinson\u2019s Disease or Rheumatoid Arthritis, by assessment type, assessment outcome and year 20082<\/sup> to 20174<\/sup>, Great Britain<\/strong><\/p> <\/strong><\/p><\/td> <\/strong><\/p><\/td> \u2018000s<\/em><\/strong><\/p><\/td><\/tr> Condition<\/strong><\/p><\/td> Year of completed assessment<\/strong><\/p><\/td><\/tr> Assessment type - Outcome<\/p><\/td> 08<\/strong><\/p><\/td> 09<\/strong><\/p><\/td> 10<\/strong><\/p><\/td> 11<\/strong><\/p><\/td> 12<\/strong><\/p><\/td> 13<\/strong><\/p><\/td> 14<\/strong><\/p><\/td> 15<\/strong><\/p><\/td> 16<\/strong><\/p><\/td> 17<\/strong><\/p><\/td> Total<\/strong><\/p><\/td><\/tr> Cystic Fibrosis<\/strong><\/p><\/td><\/tr> Initial - Support Group<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 1.0<\/strong><\/p><\/td><\/tr> Initial - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/strong><\/p><\/td><\/tr> Initial - Fit for Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/strong><\/p><\/td><\/tr> Repeat - Support Group<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.6<\/strong><\/p><\/td><\/tr> Repeat - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/strong><\/p><\/td><\/tr> Repeat - Fit For Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> IBR - Support Group<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.6<\/strong><\/p><\/td><\/tr> IBR - WRAG<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/strong><\/p><\/td><\/tr> IBR - Fit for Work<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> Motor Neurone Disease<\/strong><\/p><\/td><\/tr> Initial - Support Group<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 1.5<\/strong><\/p><\/td><\/tr> Initial - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/strong><\/p><\/td><\/tr> Initial - Fit for Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> Repeat - Support Group<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> 0.3<\/strong><\/p><\/td><\/tr> Repeat - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> Repeat - Fit For Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> IBR - Support Group<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.2<\/strong><\/p><\/td><\/tr> IBR - WRAG<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> IBR - Fit for Work<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> Multiple Sclerosis<\/strong><\/p><\/td><\/tr> Initial - Support Group<\/p><\/td> -<\/p><\/td> 0.5<\/p><\/td> 0.7<\/p><\/td> 0.9<\/p><\/td> 1.5<\/p><\/td> 1.3<\/p><\/td> 1.8<\/p><\/td> 1.5<\/p><\/td> 1.1<\/p><\/td> 0.7<\/p><\/td> 9.7<\/strong><\/p><\/td><\/tr> Initial - WRAG<\/p><\/td> -<\/p><\/td> 0.7<\/p><\/td> 0.9<\/p><\/td> 0.5<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> 2.8<\/strong><\/p><\/td><\/tr> Initial - Fit for Work<\/p><\/td> -<\/p><\/td> 0.4<\/p><\/td> 0.4<\/p><\/td> 0.3<\/p><\/td> 0.3<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> 2.2<\/strong><\/p><\/td><\/tr> Repeat - Support Group<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.2<\/p><\/td> 0.8<\/p><\/td> 2<\/p><\/td> 2<\/p><\/td> 1.8<\/p><\/td> 0.4<\/p><\/td> 3.7<\/p><\/td> 1.1<\/p><\/td> 9.7<\/strong><\/p><\/td><\/tr> Repeat - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.4<\/p><\/td> 0.6<\/p><\/td> 0.7<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> 1.7<\/strong><\/p><\/td><\/tr> Repeat - Fit For Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.5<\/strong><\/p><\/td><\/tr> IBR - Support Group<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 1.4<\/p><\/td> 4.2<\/p><\/td> 7<\/p><\/td> 2.3<\/p><\/td> 0.7<\/p><\/td> 0.5<\/p><\/td> 0.1<\/p><\/td> 16.2<\/strong><\/p><\/td><\/tr> IBR - WRAG<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 0.5<\/p><\/td> 1.1<\/p><\/td> 0.9<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 2.6<\/strong><\/p><\/td><\/tr> IBR - Fit for Work<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.3<\/strong><\/p><\/td><\/tr> Parkinsons Disease<\/strong><\/p><\/td><\/tr> Initial - Support Group<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.3<\/p><\/td> 0.3<\/p><\/td> 0.4<\/p><\/td> 0.4<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 2.1<\/strong><\/p><\/td><\/tr> Initial - WRAG<\/p><\/td> -<\/p><\/td> 0.2<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.8<\/strong><\/p><\/td><\/tr> Initial - Fit for Work<\/p><\/td> -<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.8<\/strong><\/p><\/td><\/tr> Repeat - Support Group<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.3<\/p><\/td> 0.3<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.4<\/p><\/td> 0.1<\/p><\/td> 1.3<\/strong><\/p><\/td><\/tr> Repeat - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.4<\/strong><\/p><\/td><\/tr> Repeat - Fit For Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/strong><\/p><\/td><\/tr> IBR - Support Group<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 0.1<\/p><\/td> 0.3<\/p><\/td> 0.6<\/p><\/td> 0.2<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 1.3<\/strong><\/p><\/td><\/tr> IBR - WRAG<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.3<\/strong><\/p><\/td><\/tr> IBR - Fit for Work<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> Rheumatoid Arthritis<\/strong><\/p><\/td><\/tr> Initial - Support Group<\/p><\/td> -<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.3<\/p><\/td> 0.6<\/p><\/td> 0.6<\/p><\/td> 1.0<\/p><\/td> 0.9<\/p><\/td> 0.5<\/p><\/td> 0.3<\/p><\/td> 4.5<\/strong><\/p><\/td><\/tr> Initial - WRAG<\/p><\/td> -<\/p><\/td> 0.7<\/p><\/td> 0.9<\/p><\/td> 0.6<\/p><\/td> 0.6<\/p><\/td> 0.3<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 3.7<\/strong><\/p><\/td><\/tr> Initial - Fit for Work<\/p><\/td> -<\/p><\/td> 0.8<\/p><\/td> 0.9<\/p><\/td> 0.6<\/p><\/td> 0.7<\/p><\/td> 0.5<\/p><\/td> 0.3<\/p><\/td> 0.6<\/p><\/td> 0.6<\/p><\/td> 0.3<\/p><\/td> 5.2<\/strong><\/p><\/td><\/tr> Repeat - Support Group<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.3<\/p><\/td> 0.8<\/p><\/td> 1.4<\/p><\/td> 1.5<\/p><\/td> 0.4<\/p><\/td> 1.9<\/p><\/td> 0.8<\/p><\/td> 5.9<\/strong><\/p><\/td><\/tr> Repeat - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.4<\/p><\/td> 0.8<\/p><\/td> 1.2<\/p><\/td> 0.8<\/p><\/td> 0.4<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 3<\/strong><\/p><\/td><\/tr> Repeat - Fit For Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.3<\/p><\/td> 0.3<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.4<\/p><\/td> 0.2<\/p><\/td> 1.7<\/strong><\/p><\/td><\/tr> IBR - Support Group<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 0.5<\/p><\/td> 1.5<\/p><\/td> 2.6<\/p><\/td> 1.1<\/p><\/td> 0.5<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> 6.6<\/strong><\/p><\/td><\/tr> IBR - WRAG<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 0.8<\/p><\/td> 2.2<\/p><\/td> 1.7<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 5<\/strong><\/p><\/td><\/tr>